Balanced news tone
News Sentiment
INO sentiment intelligence
Inovio Pharmaceuticals, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-5.9% over one week, +2.6% over four weeks, trend inactive, and below fair value.
INOVIO PHARMACEUTICALS, INC. SEC Filing (Jul 13, 2026)
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
INOVIO PHARMACEUTICALS, INC. SEC Filing (Jul 13, 2026)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 10:11
- Source
- Stock Titan
INO News | INOVIO PHARMACEUTICALS INC (NASDAQ:INO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 00:10
- Source
- ChartMill
Inovio Pharmaceuticals (NASDAQ: INO) files $300M shelf registration, notes BLA PDUFA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Rare disease DNA medicine on agenda as INOVIO hits June conferences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Stock Titan
Is Inovio Pharmaceuticals (INO) a High-Stakes Bet Ahead of its October PDUFA Date
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 20:06
- Source
- Kavout | AI
Inovio: All Eyes On INO-3107 As Binary FDA Decision Looms (NASDAQ:INO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Seeking Alpha
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- PR Newswire
Is Inovio (INO) Turning Fresh DNA Medicine Data Into a More Coherent Investment Story?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 May 2026 07:00
- Source
- simplywall.st
INO Stock Jumps As Inovio Showcases DNA Medicine Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 May 2026 07:00
- Source
- timothysykes.com
INOVIO to discuss Q1 results and business update in May 13 webcast
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 May 2026 07:00
- Source
- Stock Titan
INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm
- Tone
- Negative 18/100
- Event
- Regulatory and legal
- Published
- 07 Apr 2026 07:00
- Source
- PR Newswire
Inovio (INO) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2026 07:00
- Source
- Market source
INOVIO Announces Pricing of $17.5 Million Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- PR Newswire
INOVIO Announces Proposed Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Apr 2026 07:00
- Source
- PR Newswire
Biotech INOVIO seeks buyers for stock plus two warrant series
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Apr 2026 07:00
- Source
- Stock Titan
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- PR Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Mar 2026 08:00
- Source
- PR Newswire
Inovio Pharmaceuticals Spotlights INO-3107 BLA Acceptance, FDA Talks Ahead of Oct. 30 PDUFA Date
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Feb 2026 08:00
- Source
- Market source
Inovio Pharmaceuticals, Inc. Stock Alert: INO Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 26 Feb 2026 08:00
- Source
- PR Newswire
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Nov 2025 08:00
- Source
- PR Newswire
INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Aug 2025 07:00
- Source
- PR Newswire
Inovio Pharmaceuticals Announces Reverse Stock Split Date
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Nov 2017 23:27
- Source
- PR Newswire